Inotiv, Inc. — Director's Dealing 2015

Jun 22, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2015-06-18

Reporting Person: Lemke Jacqueline M (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-18	Common Shares	M	125000	$1.38	Acquired	153000	Direct
2015-06-18	Common Shares	M	500	$1.40	Acquired	153500	Direct
2015-06-18	Common Stock	F	96815	$2.12	Disposed	56685	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-18	Non-Qualified Option to Purchase Common Shares	$1.38	M	125000	Disposed	2022-04-09	Common Shares (125000)	Direct
2015-06-18	Option to Purchase Common Shares	$1.40	M	500	Disposed	2023-01-16	Common Shares (500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	3000	Indirect

Footnotes

F1: The reporting person acts as custodian for accounts which hold these shares for the benefit of the reporting person's minor children. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

F2: The option vested and became exercisable in two equal installments on March 31, 2013 and March 31, 2014.

F3: The option vested and became exercisable in two equal installments on January 16, 2014 and January 16, 2015.